TAB 4
	International multicenter clinical study - The use of preparations containing glycyrhizinic acid
	in dermatology practice - Survey of basic patients data - group Condyloma accuminata
	Num	Condyloma accuminata	Men	ø Age	Women	ø Age	A	B	C	D	DE	DT	PE	PT	E
	1	spray	L.F.	25	-	-	5	7	0	0	1	1	2	2	0
	2	spray	-	-	L.Ž.	19	4	10	0	0	2	2	1	2	0
	3	spray	R.L.	29	-	-	5	14	0	0	1	1	1	1	0
	4	spray	-	-	S.D.	44	4	60	0	0	1	2	1	3	0
	5	spray	S.J.	45	-	-	4	90	0	0	2	1	2	2	0
	6	spray	-	-	N.E.	24	5	30	0	0	1	1	1	1	0
	7	spray	D.P.	25	-	-	4	18	0	0	1	1	1	1	0
	8	spray	-	-	P.S.	24	4	8	0	0	1	1	1	1	0
	9	spray	K.H.	25	-	-	4	6	0	0	1	1	1	1	0
	10	spray	-	-	C.P.	21	4	18	0	0	1	1	1	1	0
	Summary		-	29,8	-	26,4	4,30	####	-	-	-	-	-	-	-
	Legend
	A - number of aplication/day
	B - duration of aplication/day
	C - Undesirable effects
	D - Relaps
	DE/DT - evaluation of doctor - effect/tolerance
	PE/PT- eavaluation of patient - effect/tolerance
	E - interruption of application
	Effect					Tolerance
	1 - very good					1- very good
	2 - good					2 - good
	3 - no effect					3 - no effect
	4 - degradation					4 - exacerbation
	Graph 7
	International multicenter clinical study - The use of preparations containing glycyrhizinic acid
	in dermatology practice - Survey of basic patients data - group Condyloma accuminata
	Graph 8
	International multicenter clinical study - The use of preparations containing glycyrhizinic acid
	in dermatology practice - Survey of basic patients data - group Condyloma accuminata